missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Cell Culture Media, Supplements, and Reagents
  4. Cell Culture Reagents, Antibiotics and Supplements
  5. Additional Cell Culture Reagents and Supplements
  6. 17168051

STEMCELL Technologies StemSpan™ CD34+ Expansion Supplement (10X)

Product Code. 17168051
Encompass
Change view
Click to view available options
Quantity:
10 mL
Unit Size:
10mL
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Product Code. Quantity unitSize
17168051 10 mL 10mL
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
This item is not returnable. View return policy
Product Code. 17168051 Supplier STEMCELL Technologies Supplier No. 02691

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Serum-free culture supplement for expansion of human CD34+ hematopoietic cells

  • StemSpan™ Leukemic Cell Culture Kit has been developed for the in vitro culture and expansion of malignant cells and has been tested on chronic myeloid leukemia (CML) and acute myeloid leukemia (AML) samples
  • This optimized protocol allows users to expand, culture, and use malignant cells for drug screening
  • StemSpan™ Leukemic Cell Culture Kit includes the serum-free medium SFEM II (Catalog #09605), StemSpan™ CD34+ Expansion Supplement (10X; Catalog #02691), and small molecule UM729 (Catalog #72332)

Specifications

Cell Type Cancer Cells and Cell Lines, Hematopoietic Stem and Progenitor Cells, Leukemia/Lymphoma Cells
For Use With (Application) Cell Culture, Expansion, Toxicity Assay
Quantity 10 mL
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.